Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 6/20 | 0.63 |
| ▸ | LAP3 | P28838 | 2/20 | 0.59 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.53 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.53 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.53 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.53 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.52 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.52 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10579638 | 0.98 | FDPS (0.65) | FDPSLAP3S1PR2S1PR1S1PR3 | |
| SCHEMBL30728393 | 0.98 | FDPS (0.65) | FDPSLAP3S1PR2S1PR1S1PR3 | |
| SCHEMBL3977686 | 0.98 | FDPS (0.65) | FDPSLAP3S1PR2S1PR1S1PR3 | |
| SCHEMBL2901306 | 0.98 | FDPS (0.65) | FDPSLAP3S1PR2S1PR1S1PR3 | |
| SCHEMBL28339509 | 0.98 | FDPS (0.65) | FDPSLAP3S1PR2S1PR1S1PR3 | |
| SCHEMBL7820207 | 0.98 | FDPS (0.65) | FDPSLAP3S1PR2S1PR1S1PR3 | |
| SCHEMBL2702214 | 0.98 | FDPS (0.65) | FDPSLAP3S1PR2S1PR1S1PR3 | |
| SCHEMBL7818091 | 0.98 | FDPS (0.65) | FDPSLAP3S1PR2S1PR1S1PR3 | |
| SCHEMBL10946890 | 0.98 | FDPS (0.65) | FDPSLAP3S1PR2S1PR1S1PR3 | |
| SCHEMBL655553 | 0.96 | FDPS (0.63) | FDPSLAP3S1PR2S1PR1S1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12371516-B2 | Aged lanthanide-based catalyst systems and their use in the preparation of cis-1,4-polydienes | BRIDGESTONE CORPORATION (JP) | 2025-07-29 | — | — | US | disclosed |
| US-20230183399-A1 | AGED LANTHANIDE-BASED CATALYST SYSTEMS AND THEIR USE IN THE PREPARATION OF CIS-1,4-POLYDIENES | BRIDGESTONE CORPORATION (JP) | 2023-06-15 | — | — | US | disclosed |
| US-9469706-B2 | Polymers functionalized with unsaturated heterocycles containing a protected amino group | BRIDGESTONE CORPORATION (JP) | 2016-10-18 | — | — | US | disclosed |
| US-9458270-B2 | Method for producing polydienes and polydiene copolymers with reduced cold flow | BRIDGESTONE CORPORATION (JP) | 2016-10-04 | — | — | US | disclosed |
| US-9447213-B2 | Polymers functionalized with polycyano compounds | BRIDGESTONE CORPORATION (JP) | 2016-09-20 | — | — | US | disclosed |
| US-9376508-B2 | Polymers and use thereof in preparation of high impact polymeric compositions | BRIDGESTONE CORPORATION (JP) | 2016-06-28 | — | — | US | disclosed |
| US-9353205-B2 | Processes for the preparation of high-cis polydienes | BRIDGESTONE CORPORATION (JP) | 2016-05-31 | — | — | US | disclosed |
| US-9315599-B2 | Functionalized polymers | BRIDGESTONE CORPORATION (JP) | 2016-04-19 | — | — | US | disclosed |
| US-20150299350-A1 | Processes For The Preparation Of High-Cis Polydienes | BRIDGESTONE CORPORATION (JP) | 2015-10-22 | — | — | US | disclosed |
| US-20150267031-A1 | POLYMERS FUNCTIONALIZED WITH HETEROCYCLIC NITRILE COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2015-09-24 | — | — | US | disclosed |
| US-20110184137-A1 | CATALYSTS FOR PREPARING CIS 1,4-POLYDIENES | BRIDGESTONE CORPORATION (JP) | 2011-07-28 | — | — | US | disclosed |
| US-20110152449-A1 | POLYMERS FUNCTIONALIZED WITH POLYOXIME COMPOUNDS AND METHODS FOR THEIR MANUFACTURE | BRIDGESTONE CORPORATION (JP) | 2011-06-23 | — | — | US | disclosed |
| US-7902309-B2 | Process and catalyst system for polydiene production | BRIDGESTONE CORPORATION (JP) | 2011-03-08 | — | — | US | disclosed |
| US-20100317818-A1 | POLYMERS FUNCTIONALIZED WITH HALOSILANES CONTAINING AN AMINO GROUP | BRIDGESTONE CORPORATION (JP) | 2010-12-16 | — | — | US | disclosed |
| US-20100216956-A1 | PROCESS AND CATALYST SYSTEM FOR POLYDIENE PRODUCTION | BRIDGESTONE CORPORATION (JP) | 2010-08-26 | — | — | US | disclosed |
| US-7741418-B2 | Process for producing polydienes | BRIDGESTONE CORPORATION (JP) | 2010-06-22 | — | — | US | disclosed |
| US-20100137520-A1 | Branched Polymers and Methods for Their Synthesis and Use | BRIDGESTONE CORPORATION (JP) | 2010-06-03 | — | — | US | disclosed |
| US-20090171046-A1 | PROCESS FOR PRODUCING POLYDIENES | BRIDGESTONE CORPORATION (JP) | 2009-07-02 | — | — | US | disclosed |
| US-20090171035-A1 | POLYMERS FUNCTIONALIZED WITH POLYIMINE COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2009-07-02 | — | — | US | disclosed |
| US-20090099325-A1 | POLYMERS FUNCTIONALIZED WITH HETEROCYCLIC NITRILE COMPOUNDS | BRIDGESTONE CORPORATION | 2009-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317818-A1 | POLYMERS FUNCTIONALIZED WITH HALOSILANES CONTAINING AN AMINO GROUP | MSN, PARG, ALG1 | FDPS 1897/4885LAP3 471/4885S1PR2 3333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.